🇺🇸 FDA
Patent

US 6348481

Pharmaceutical composition for angiotensin II-mediated diseases

expired A61KA61K31/495A61K31/54

Quick answer

US patent 6348481 (Pharmaceutical composition for angiotensin II-mediated diseases) held by Takeda Chemical Industries Ltd. expires Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Feb 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/495, A61K31/54, A61K45/06